Can selective serotonin inhibitor drugs in elderly patients in nursing homes be reduced?

References

• Pitkala KH, Strandberg TE, Tilvis RS. Is it possible to reduce polypharmacy in the elderly? A randomized, controlled trial. Drug Aging 2001; 18: 143–9
   PubMedGoogle Scholar
• Barat I, Andreasen F, Damsgaard EM. The consumption of drugs by 75-year-old individuals living in their own homes. Eur J Clin Pharmacol 2000; 56: 501–9
   PubMed Web of Science ®Google Scholar
• Furniss L, Craig SK, Burns A. Medication use in nursing homes for elderly people. Int J Geriatr Psychiatry 1998; 13: 433–9
   PubMed Web of Science ®Google Scholar
• Meijer WE, Heerdink ER, Nolen WA, Herings RM, Leufkens HG, Egberts AC. Association of risk of abnormal bleeding with degree of serotonin reuptake inhibition by antidepressants. Arch Intern Med 2004; 164: 2367–70
   PubMedGoogle Scholar
• Abajo de FJ, Garcia Rodriguez LA, Montero D. Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: Population based case-control study. BMJ 1999; 319: 1106–9
   PubMedGoogle Scholar
• Dalton SO, Johansen C, Mellemkjaer L, Norgard B, Sorensen HT, Olsen JH. Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: A population-based cohort study. Arch Intern Med 2003; 163: 59–64
   PubMed Web of Science ®Google Scholar
• Perri M III, Menon AM, Deshpande AD, Shinde SB, et al. Adverse outcomes associated with inappropriate drug use in nursing homes. Ann Pharmacother 2005; 39: 405–11
   PubMed Web of Science ®Google Scholar
• Khunti K, Kinsella B. Effect of systematic review of medication by general practitioner on drug consumption among nursing-home residents. Age Ageing 2000; 29: 451–3
   PubMed Web of Science ®Google Scholar
• Bhatia SC, Bhatia SK. Major depression: Selecting safe and effective treatment. Am Fam Physician 1997; 55: 1683–98
   PubMedGoogle Scholar
• Farmakoterapi vid unipolär depression hos vuxna och äldre – Behandlingsrekommendation från Läkemedelsverket 5:2004 (Treatment of depression among the elderly). Stockholm: Information from Medical Products Agency 5; 2004.
   Google Scholar
• Behandling av depressionssjukdomar. En systematisk litteraturöversikt (Treatment of depression: A systematic literature review). SBU-rapport nr 166. Stockholm: Swedish Council on Technology Assessment in Health Care; 2004.
   Google Scholar
• Nelson JC. Diagnosing and treating depression in the elderly. J Clin Psychiatry 2001; 62: 18–22
   PubMed Web of Science ®Google Scholar
• Keane SM, Sells S. Recognizing depression in the elderly. J Gerontol Nurs 1990; 16: 21–5
   PubMedGoogle Scholar
• Montgomery SA, Åsberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979; 134: 383–9
   Web of Science ®Google Scholar
• Kurlowicz LH, Evans LK, Strumpf NE, Maislin G. A psychometric evaluation of Cornell Scale for Depression in Dementia in a frail, nursing home population. Am J Geriatr Psychiatry 2002; 10: 600–8
   PubMedGoogle Scholar
• Mottram P, Wilson K, Copeland J. Validation of the Hamilton Depression Rating Scale and Montgomery and Asberg Rating Scales in terms of AGECAT depression cases. Int J Geriatr Psychiatry 2000; 15: 1113–19
   PubMed Web of Science ®Google Scholar
• Ulfvarson J, Adami J, Wredling R, Kjellman B, Reilly M, Bahr C v. Controlled withdrawal of selective serotonin inhibitor drugs in elderly patients in nursing homes with no indication of depression. Eur J Clin Pharmacol 2003; 59: 735–40
   PubMedGoogle Scholar
• Merlo J, Gullberg B. Controlled withdrawal of selective serotonin reuptake inhibitors in elderly patients in nursing homes with no indication of depression – a commentary. Eur J Clin Pharmacol 2005; 61: 321–3
   PubMedGoogle Scholar
• Ruths S, Straand J, Nygaard HA. Multidisciplinary medication review in nursing home residents: What are the most significant drug-related problems? The Bergen District Nursing Home (BEDNURS) study. Qual Saf Health Care 2003; 12: 176–80
   PubMedGoogle Scholar
• Kvaliteten i äldres läkemedelsanvändning. Källa-projektet. En tillämpning av kvalitetsindikatorer för analys av läkemedelsanvändningen hos äldre med dosexpedition på kommunala äldreboenden i ett svenskt län (Quality in drug treatment of elderly. The Källa project: Analysis of drug treatment in nursing homes in a Swedish county using quality indicators. The National Board of Health and Welfare). Stockholm: Socialstyrelsen; 2004.
   Google Scholar
• Van Walraven C, Mamdani MM, Wells PS, Williams JI. Inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding in elderly patients: retrospective cohort study. BMJ 2001; 323: 655–8
   PubMed Web of Science ®Google Scholar
• Movig KL, Leufkens HG, Belitser SV, Lenderink AW, Egberts AC. Selective serotonin reuptake inhibitor-induced urinary incontinence. Pharmacoepidemiol Drug Saf 2002; 11: 271–9
   PubMedGoogle Scholar
• Pacher P, Ungvari Z. Selective serotonin-reuptake inhibitor antidepressants increase the risk of falls and hip fractures in elderly people by inhibiting cardiovascular ion channels. Med Hypotheses 2001; 57: 469–71
   PubMedGoogle Scholar
• Odeh M, Beny A, Oliven A. Severe symptomatic hyponatremia during citalopram therapy. Am J Med Sci 2001; 321: 159–60
   PubMed Web of Science ®Google Scholar
• Liu BA, Mittmann N, Knowles SR, Shear NH. Hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone associated with the use of selective serotonin reuptake inhibitors: A review of spontaneous reports. Can Med Assoc J 1996;155:519–27. Review. Erratum in: Can Med Assoc J 1996;155:1043.
   PubMed Web of Science ®Google Scholar